D
Madrigal Pharmaceuticals, Inc. MDGL
$424.00 $11.772.85% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 212.80M 137.25M 103.32M 62.18M 14.64M
Total Other Revenue -- -- -- -- --
Total Revenue 212.80M 137.25M 103.32M 62.18M 14.64M
Cost of Revenue 9.07M 4.51M 3.45M 2.15M 636.00K
Gross Profit 203.74M 132.74M 99.88M 60.02M 14.00M
SG&A Expenses 196.86M 167.88M 141.22M 107.59M 105.45M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 260.00M 216.56M 170.32M 178.48M 177.18M
Operating Income -47.20M -79.31M -67.00M -116.30M -162.54M
Income Before Tax -42.28M -73.24M -59.42M -106.96M -151.97M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -42.28M -73.24M -59.42M -106.96M -151.97M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -42.28M -73.24M -59.42M -106.96M -151.97M
EBIT -47.20M -79.31M -67.00M -116.30M -162.54M
EBITDA -46.83M -78.93M -66.63M -116.01M -162.27M
EPS Basic -1.90 -3.32 -2.71 -4.92 -7.10
Normalized Basic EPS -1.19 -2.07 -1.69 -3.07 -4.44
EPS Diluted -1.90 -3.32 -2.71 -4.92 -7.10
Normalized Diluted EPS -1.19 -2.07 -1.69 -3.07 -4.44
Average Basic Shares Outstanding 22.21M 22.09M 21.93M 21.75M 21.40M
Average Diluted Shares Outstanding 22.21M 22.09M 21.93M 21.75M 21.40M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --